Design of a Non-Interventional Post-Marketing Study to Assess the Long-Term Safety and Effectiveness of Ocrelizumab in German Real World Multiple Sclerosis Cohorts – The CONFIDENCE Study Protocol

BMC Neurology - United Kingdom
doi 10.1186/s12883-020-01667-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

PEARL: A Non-Interventional Study of Real-World Alirocumab Use in German Clinical Practice

Drugs - Real World Outcomes
Pharmacology
2019English

Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

Advances in Therapy
MedicinePharmacology
2019English

Real-World, Non-Interventional, Observational Study of Hydroxyzine Hydrochloride in Chronic Pruritus: A Prospective, Non-Comparative Study

Dermatology and Therapy
Dermatology
2019English

A 1-Year Cross-Sectional Analysis of Non-Interventional Post-Marketing Study Protocols Submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)

European Journal of Clinical Pharmacology
MedicinePharmacology
2013English

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary
EndocrinologyMetabolismDiabetes
2019English

AMEND Study Protocol: A Case–control Study to Assess the Long-Term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy